Our team

Meet Our Experienced Team

Our management team and Scientific Advisory Board bring decades of experience and cutting-edge knowledge to the forefront in discovering and developing leading-edge medicines. Collectively, we are dedicated to discovering and developing new therapies that will change the world of oncology, dermatology, and more.

Leadership Team

Brian Lestini, MD, PhD

Chief Executive Officer

Biren Amin, MBA

Chief Financial and Strategy Officer

Nushmia Khokhar, MD

Chief Medical Officer

Jeffrey Wasserman, JD

Chief Legal Officer

W. Robert Bishop, PhD

Vice President, Cancer Biology

Palaniappan Kulanthaivel, PhD

Vice President, Clinical Pharmacology

Vijaypal Reddy, DVM, PhD, DABT

Vice President, Nonclinical Safety

Deb Chapman

Executive Director, Clinical Operations

Keith Brosie

Director, Project Management

Scientific Advisory Board

Manmeet Ahluwalia, MD, FACP, MBA

Chief of Solid Tumor Medical Oncology, Deputy Director and Chief Scientific Officer, Miami Cancer Institute

Daniel Cahill, MD, PhD

Professor, Neurosurgery & Oncology, Harvard Medical
Director of Neuro-Oncology, Massachusetts General Hospital

Moses Chao, PhD

Professor, NYU Langone Medical Center

Timothy Cloughsey, MD

Director, Neuro-Oncology Program at UCLA Medical; Professor of Neurology

George Demetri, MD

Professor, Harvard, Dana Farber; Director of Sarcoma Center
BOD & SAB, Blueprint Medicines

Lori Kunkel, MD

Former CMO & BOD, LoxoOncology; Former CMO, Pharmacyclics
BOD/SAB, Elevation, Rain, Maverick, Nurix, Curis

Michael Lim, MD

Chair of Neurosurgery at Stanford Medicine; former professor of neurosurgery & oncology, Johns Hopkins

David Reardon, MD

Former President of the Society for Neuro-Oncology
Director of Center for Neuro-Oncology, DFCI

John Sampson, MD, PhD, MBA, MHSc

Professor & former Chair of Neurosurgery, Duke University
Member, National Academy of Medicine

Dave Solit, MD

Geoffrey Beene Chair; Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center

Katherine Warren, MD

Clinical Director of Pediatric Neuro-Oncology, Boston Children’s/DFCI; former Head of Pediatric Neuro-Oncology Group, National Cancer Institute

Board of Directors

John Childs, MBA

Chairman & CEO, JW Childs Associates L.P.

Vlad Coric, MD

CEO, Biohaven Ltd.

Larry Feinberg, MBA

Managing Partner, Oracle Investment Management Inc.

Jordan Leef

Co-Founder of Pyramid Biosciences Inc.

Kollol Pal, PhD, MBA

Scientific Co-Founder of Pyramid Biosciences Inc.
Want to know more? Contact us today.